MUKHTAR, S.; HARIS, M. Teplizumab: an FDA- approved drug, marks milestone in treatment of type 1 diabetes . International Journal of Scientific Reports, [S. l.], v. 10, n. 1, p. 29–30, 2023. DOI: 10.18203/issn.2454-2156.IntJSciRep20233870. Disponível em: https://www.sci-rep.com/index.php/scirep/article/view/1286. Acesso em: 26 sep. 2025.